Feb 04, 2021 / 09:00AM GMT
Presentation
Feb 04, 2021 / 09:00AM GMT
=====================
Corporate Participants
=====================
* Osamu Okuda
Chugai Pharmaceutical Co., Ltd. - President, COO & Representative Director
* Shinji Hidaka
Chugai Pharmaceutical Co., Ltd. - VP & Head of Marketing & Sales Division
* Tatsuro Kosaka
Chugai Pharmaceutical Co., Ltd. - Chairman & CEO
* Tetsuya Yamaguchi
Chugai Pharmaceutical Co., Ltd. - Senior VP & Head of Project & Lifecycle Management Unit and In Charge of Corporate Planning Dept.
* Toshiaki Itagaki
Chugai Pharmaceutical Co., Ltd. - CFO & EVP - Fin. & Acct., Corp. Comm., Purchasing, Dig. Strategy & IT Sol and Head of Fin. Sup. Div.
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Global Markets Japan Inc., Research Division - MD & Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co.
Chugai Pharmaceutical Co Ltd
(MEX:4519N)
MXN
825.61
(0%)
Market Cap: 1.31 Tn
Enterprise Value: 1.21 Tn
PE Ratio: 26.66
PB Ratio: 6.32
GF Score: 97/100 Full Year 2020 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript
Feb 04, 2021 / 09:00AM GMT
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot